Page 51 Manual de rotação de opióides

20. Fine PG, Portenoy RK. “Ad Hoc Expert Panel on Evidence Review and Guidelines for Opioid Rotation.
Establishing “best practices” for opioid rotation: Conclusions of an expert panel.” J Pain Symptom Manage-
ment 38 (2009): 418-25.
21. Mercadante S, Bruera E. “Opioid switching: A systematic and critical review.” Cancer Treat Rev 32 (2006):
304-15.
22. Mercadante S, Ferrera P, Villari P et al. “Frequency, indications, outcomes, and predictive factors of opioid
switching in an acute palliative care unit.” J Pain Symptom Management 37 (2009): 632-41.
23. Quang-Cantagrel ND, Wallace MS, Magnuson SK. “Opioid substitution to improve the effectiveness of
chronic noncancer pain control: A chart review.” Anesth Analg 90 (2000): 933-7.
24. Riley JL, Ross JR, Rutter D, et al. “No pain relief from morphine? Individual variation in sensitivity to morphi-
ne and the need to switch to an alternative opioid in cancer patients.” Support Care Cancer 14 (2006): 56-64.
25. Schinkel AH. “The physiological function of drug-transporting P-glycoproteins.” Semin Cancer Biol 3
(1997): 61-170.
26. Dagenais C, Graff CL, Pollack GM. “Variable modulation of opioid brain uptake by P-glycoprotein in mice.”
Biochem Pharmaco 67 (2004): 269-276.
27. Marzolini C, Paus E, Buclin T, et al. “Polymorphisms in human MDRl (P-glycoprotein): Recent advances
and clinical relevance.” Clin Pharmacol Ther 75 (2004): 13-33.
28. Quigley C. “Opioid switching to improve pain relief and drug tolerability.” Cohcrane Database of Systema-
tic Reviews. Vol. Art. No:CD004847. n.º 3. DOI: 10.1002/14651858.CD004847, 2004
29. “RCM Durogesic .”
®
30. “RCM Transtec .”
®
31. Rethinking. “Opioid Equivalence.” Pain Clinical Updates (IASP) X, n.º 4 (September 2002).
32. Mercadante S, Caraceni A. “Conversion ratios for opioid switching in the treatment of cancer pain: a
systematic review.” Palliative Medicine 25, n.º 5 (2011): 504-515.
33. Shaheen P, Walsh D et al. “Opioid Equianalgesic Tables: Are they all equally dangerous? .” J Pain Symp-
tom Management 38, n.º 3 (2009): 409-417.
34. Knotkova H, Fine P, Portenoy R. “Opioid Rotation: The Science and the Limitations of the Equianalgesic
Dose Table.” J Pain Symptom Management 38, n.º 3 (Setembro 2009): 426-439.
35. González-Barboteo J, Trelis-Navarro J. “Rotación de opioids: una alternativa en el tratamiento del dolor
refractario en pacientes con cancer.” Med Clin (Barc) 135, n.º 13 (2010): 617-622.
36. EAPC. “Use of Opioid Analgesics in the Treatment of Cancer Pain: Evidence-based recommendations
from the EAPC.” Lancet Oncol 13 (Feb 2012): 58-68.
37. Eastern Metropolitan Region Palliative Care Consortium (Victoria). Opioid Conversion Ratios - Guide to
Practice 2013. www.emrpcc.org.au.
38. Zeppetella G. Successful Management of Breakthrough Pain in Cancer Patients. Evolving Medicine, 2011.

51